
    
      All patients enrolled into the study will receive standard surgery procedures indicated in
      accordance with medical care standards for the certain disease. Maxillofacial bone defects
      (formed after injuries, surgeries, excision of benign neoplasms and pseudotumors, teeth
      extraction, etc.) or areas of alveolar bone atrophy will be the filled by gene-activated
      matrix "Nucleostim". Safety and efficacy of implanted osteoplastic material will be assessed
      by physical examination, comprehensive laboratory tests, X-ray examination within 60 days
      after operation.
    
  